The global ureteral stents market is projected to grow at a steady pace during the forecast period, owing to the rising cases of kidney transplants, increasing incidence of urological diseases, and growing geriatric population. On the basis of product, the market is categorized into open-end, closed-end, double-pigtail, multiloop, and other stents. Among these, double-pigtail stents are estimated to hold the largest share in the market in 2017. The market for multiloop stents, however, is predicted to undergo to grow at the highest rate because of the increase in the prevalence of urological disorders, rise in geriatric population, and technological advancements in multiloop stents leading to reduced complications.
On the basis of end user, the Ureteral Stents Market is categorized into hospitals, clinics, and ASCs. During the forecast period, ASCs are expected to lead the market, in terms of both size and growth. During the historical period, North America held the largest share in the ureteral stents industry, because of the availability of advanced medical facilities and high prevalence of kidney stone problems in the region. However, during the forecast period, Asia-Pacific is expected to grow at the highest CAGR, because of the surging population, increasing medical awareness on these stents, growing prevalence of urological diseases, increasing initiatives of the government for the improvement of healthcare, and rising disposable income of the people in the region.
Request to Get the Sample Pages at:
According to the United States Renal Data System (USRDS), around 17,600 kidney transplants were performed in the U.S. in 2013. From 2012 to 2013, there was a 3.1% increase in the cumulative number of recipients with a functioning kidney transplant. As of December 31, 2013, the kidney transplant waiting list increased by 3%, from the previous year, to 86,965 candidates (dialysis patients only), 83% of whom awaited their first kidney transplant.
Some of the major players in the ureteral stents market are Becton, Dickinson and Company; Cook Medical LLC; B. Braun Melsungen AG; Olympus Corporation; Coloplast A/S; Medline Industries Inc.; Allium Medical Solutions Ltd.; Teleflex Incorporated; Boston Scientific Corporation; and Pnn Medical A/S.
For instance, in March 2016, Boston Scientific Corporation launched a new app, called the Ureteral Stent Tracker, to help urologists and their staff keep tabs on ureteral stents implanted in patients with kidney stones. The app was developed in partnership with the health app developer Visible Health Inc.
